| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |